Eric Hsu
Förmögenhet: 3 $ per 2026-05-31
Förmögenhet: 3 $ per 2026-05-31
Eric C.
Hsu is Senior VP-Pre-Clinical Research & Development at InMed Pharmaceuticals, Inc. since 2018.
Formerly, Dr. Hsu was VP-Scientific Affairs, Research & Operations at enGene, Inc. from 2002 to 2018.
Education includes an undergraduate degree from McGill University and a doctorate from the University of Toronto conferred in 1999.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2025-12-19 | 2 ( 0 % ) | 3 $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| INMED PHARMACEUTICALS INC. | Teknisk/Vetenskaplig/F&U Direktör | 2018-03-13 |
| Företag | Position | Slut |
|---|---|---|
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which develops non-viral gene therapies | Verksamhetschef | 2018-01-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
InMed Pharmaceuticals, Inc.
InMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures prescription-based products for dermatology and ocular diseases | Health Technology |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which develops non-viral gene therapies | Health Technology |
McGill University
McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Välj din utgåva
All finansiell information anpassad till den nationella nivån